基因型鑑定的全球市场:现状分析与预测(2021年～2027年)

全球基因型鑑定的市场规模在预测期间(2021年～2027年)中预计将以约20％的年复合成长率成长。

罕见病基因分型通过帮助确定未确诊疾病的原因并防止他们多年去医院或进行不必要的检查，从而推动市场增长。此外，癌症等疾病的日益流行也增加了对基因分型诊断的需求。

本报告提供全球基因型鑑定市场的相关调查，提供市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

• 市场定义
• 限制
• 相关利益者
• 报告所使用的货币

第2章 调查方法或假设

• 基因型鑑定市场调查流程
• 基因型鑑定市场调查手法
• 预测方法
• 受访者简介
• 基因型鑑定市场调查的主要目的

第3章 市场摘要

第4章 摘要整理

第5章 全球基因型鑑定市场上COVID-19影响

第6章 全球基因型鑑定市场收益(2019年～2027年)

第7章 市场洞察:产品/各服务形式

• 试剂和套件
• 基因型鑑定服务
• 设备
• 生物资讯学

第8章 市场洞察:各技术

• PCR
• 序列
• 电泳
• 微阵列
• 其他

第9章 市场洞察:各终端用户

• 製药及生物科技企业
• 医院及诊疗所
• 学术及政府机关
• 诊断及研究机关
• 其他

第10章 市场洞察:各地区

• 北美的基因型鑑定市场
  • 美国
  • 加拿大
  • 其他的北美
• 欧洲的基因型鑑定市场
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他的欧洲
• 亚太地区的基因型鑑定市场
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 其他的亚太地区
• 其他

第11章 基因型鑑定市场动态

• 推动市场要素
• 市场课题
• 影响分析

第12章 基因型鑑定市场机会

第13章 基因型鑑定市场趋势

第14章 相关法规

第15章 需求与供给面分析

• 需求面分析
• 供给面分析

第16章 价值链分析

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 公司概要

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Qiagen Inc.
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation
• Danaher Corporation
• Agilent Technologies
• Eurofins Scientific Inc.
• GE Healthcare Inc.
• Bio-Rad Laboratories Inc.

第19章 免责声明

Global Genotyping Market is anticipated to grow with an elevated CAGR of around 20% over the forecast period (2021-2027). Genotyping is the process of determining the DNA sequence, called a genotype, at specific positions within the genome of an individual. Sequence variations can be used as markers in linkage and association studies to determine genes relevant to specific traits or diseases.

The genotyping of rare disease help doctors pinpoint the cause of undiagnosed disorders, helping families avoid years of hospital visits and unnecessary tests. These factors are anticipated to boost the market. Furthermore, the increasing prevalence of diseases like cancer along with the surging incidences of rare diseases rises the demand for genotyping diagnostics. According to the ministry of health and welfare of the family, it is estimated that globally around 6000 to 8000 rare diseases exist with new rare diseases being reported in the medical literature regularly. The increasing interest of the global players and the institutions along with the continuous growth of the biotechnology industry also drives the market for genotyping. For instance, As per Invest India, In 2020, the Biotech industry reached a market size of $ 70.2 Bn, rising 12.3% from the previous year. The bioeconomy has observed almost a 95% increase in valuation over the period of five years.

llumina Inc., Thermo Fisher Scientific Inc., Qiagen Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, Agilent Technologies, Eurofins Scientific Inc., GE Healthcare Inc., and Bio-Rad Laboratories Inc, are some of the prominent players operating in the Genotyping market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of Genotyping devices.

Insights Presented in the Report

"Amongst Product/Services, Reagents & Kits segment holds the major share"

Based on product/services, the market is fragmented into Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics. The Reagents & Kits segment accounted for a significant market share in 2020 this is mainly due to the increasing investments in R&D and increasing demand for genetic testing drives the market for genotyping industry. However, the bioinformatic segment is expected to witness lucrative growth in the genotyping market owing to the increasing demand for software and the better databases require to store the genetic information. Furthermore, the integration of the devices with the internet and the public network also drives the segmental growth during the forecast period.

"Amongst Technology, sequencing segment is expected to hold the major share"

Based on technology, the market is segmented into PCR, sequencing, electrophoresis, microarray, and others. The PCR segment grabbed a significant market share in 2020. The continuously rising number of incidences of genetic disorders and the deaths raise the growth of the PCR. During the forecast, the sequencing segment is expected to have a considerable market share. This is mainly due to the technological advancement in sequencing technology and frequent product launches by the companies. For instance, in January 2021, Stanford Launched Clinical Whole-Genome Sequencing for Inherited Cardiovascular Testing.

"Amongst end-users, diagnostic & research segment expected to hold the major share"

Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, hospitals and clinics, academic & government institutes, diagnostic & research institutions, and others. The pharmaceutical & biotechnology companies held a significant market share in 2020. Genomics is enabling pharmaceutical companies to take a more personalized approach to drug development and is expected to result in safer and more effective drugs. However, the diagnostic & research institution segment is predicted to have a significant share in genotyping market in the future. This is mainly due to increasing investment in R&D worldwide along with an increasing number of cases of genetic disorders. For instance, as per UNESCO, Global spending on R&D has reached a record high of almost US$ 1.7 trillion. About 10 countries account for 80% of spending.

"North America represents one of the largest markets of Genotyping market"

For a better understanding of the market dynamics of the Genotyping market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. In 2020, North America dominated the Genotyping industry. This can be mainly due to the presence of well-established market players and frequent product launches along with the presence of government-funded organizations in the region. For instance, The National Human Genome Research Institute (NHGRI) is a part of the National Institutes of Health (NIH) are government organization supported and funded by the U.S government that has a record of the human genome and the genetic disorder.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts

• The report presents a quick review of overall industry performance at one glance

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

• The study comprehensively covers the market across different segments

• Deep dive regional level analysis of the industry

Customization Options:

The global genotyping market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stakeholders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Genotyping Market
• 2.2. Research Methodology of the Genotyping Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Genotyping Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL GENOTYPING MARKET COVID-19 IMPACT

6 GLOBAL GENOTYPING MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT/SERVICE TYPE

• 7.1. Reagents & Kits
• 7.2. Genotyping Services
• 7.3. Instruments
• 7.4. Bioinformatics

8 MARKET INSIGHTS BY TECHNOLOGY

• 8.1. PCR
• 8.2. Sequencing
• 8.3. Electrophoresis
• 8.4. Microarray
• 8.5. Others

9 MARKET INSIGHTS BY END-USERS

• 9.1. Pharmaceutical & Biotechnology companies
• 9.2. Hospitals and clinics
• 9.3. Academic & government institutes
• 9.4. Diagnostic & research institutions
• 9.5. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America Genotyping Market
  • 10.1.1. United States
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe Genotyping Market
  • 10.2.1. Germany
  • 10.2.2. France
  • 10.2.3. U.K.
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia Pacific Genotyping Market
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia Pacific
• 10.4. Rest of World Genotyping Market

11 GENOTYPING MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 GENOTYPING MARKET OPPORTUNITIES

13 GENOTYPING MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Illumina Inc.
• 18.2. Thermo Fisher Scientific Inc.
• 18.3. Qiagen Inc.
• 18.4. F. Hoffmann-La Roche Ltd.
• 18.5. Fluidigm Corporation
• 18.6. Danaher Corporation
• 18.7. Agilent Technologies
• 18.8. Eurofins Scientific Inc.
• 18.9. GE Healthcare Inc.
• 18.10. Bio-Rad Laboratories Inc.

19 DISCLAIMER